Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerhard Ehninger

Showing results (161-170 of 403) with videos related to

Pageof 41
Sort By:
Medizinische Klinik (Munich, Germany : 1983)|May 11, 2006
[Clinical research within the German competence net "acute and chronic leukemias"]Susanne Saussele, Ute Berger, Carlo Aul, et al.
Blood|May 10, 2013
The level of residual disease based on mutant NPM1 is an independent prognostic factor for relapse and survival in AMLNona Shayegi, Michael Kramer, Martin Bornhäuser, et al.
Plos One|September 27, 2013
Regional HLA differences in Poland and their effect on stem cell donor registry planningAlexander H Schmidt, Ute V Solloch, Julia Pingel, et al.
Molecular Biology of the Cell|January 17, 2003
Localization, dynamics, and function of survivin revealed by expression of functional survivinDsRed fusion proteins in the living cellAchim Temme, Michael Rieger, Friedemann Reber, et al.
Haematologica|June 24, 2009
Mesenchymal stem cells efficiently inhibit the proinflammatory properties of 6-sulfo LacNAc dendritic cellsRebekka Wehner, Diana Wehrum, Martin Bornhäuser, et al.
Clinical Biochemistry|December 12, 2018
Evaluation of TERT promoter mutations in urinary cell-free DNA and sediment DNA for detection of bladder cancerSebastian Stasik, Karsten Salomo, Ulrike Heberling, et al.
Transfusion|August 29, 2006
Efficacy of single-dose pegfilgrastim after chemotherapy for the mobilization of autologous peripheral blood stem cells in patients with malignant lymphoma or multiple myelomaFrank Kroschinsky, Kristina Hölig, Uwe Platzbecker, et al.
Haematologica|December 7, 2005
Single-dose pegfilgrastim for the mobilization of allogeneic CD34+ peripheral blood progenitor cells in healthy family and unrelated donorsFrank Kroschinsky, Kristina Hölig, Kirsten Poppe-Thiede, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2009
Pharmacogenetic analyses of a phase III trial in metastatic gastroesophageal adenocarcinoma with fluorouracil and leucovorin plus either oxaliplatin or cisplatin: a study of the arbeitsgemeinschaft internistische onkologieEray Goekkurt, Salah-Eddin Al-Batran, Jörg T Hartmann, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 13, 2009
Graft-versus-host disease prophylaxis with everolimus and tacrolimus is associated with a high incidence of sinusoidal obstruction syndrome and microangiopathy: results of the EVTAC trialUwe Platzbecker, Malte von Bonin, Eray Goekkurt, et al.
Pageof 41

Showing results (161-170 of 403) with videos related to

Sort By:
Pageof 41
Medizinische Klinik (Munich, Germany : 1983)|May 11, 2006
[Clinical research within the German competence net "acute and chronic leukemias"]Susanne Saussele, Ute Berger, Carlo Aul, et al.
Blood|May 10, 2013
The level of residual disease based on mutant NPM1 is an independent prognostic factor for relapse and survival in AMLNona Shayegi, Michael Kramer, Martin Bornhäuser, et al.
Plos One|September 27, 2013
Regional HLA differences in Poland and their effect on stem cell donor registry planningAlexander H Schmidt, Ute V Solloch, Julia Pingel, et al.
Molecular Biology of the Cell|January 17, 2003
Localization, dynamics, and function of survivin revealed by expression of functional survivinDsRed fusion proteins in the living cellAchim Temme, Michael Rieger, Friedemann Reber, et al.
Haematologica|June 24, 2009
Mesenchymal stem cells efficiently inhibit the proinflammatory properties of 6-sulfo LacNAc dendritic cellsRebekka Wehner, Diana Wehrum, Martin Bornhäuser, et al.
Clinical Biochemistry|December 12, 2018
Evaluation of TERT promoter mutations in urinary cell-free DNA and sediment DNA for detection of bladder cancerSebastian Stasik, Karsten Salomo, Ulrike Heberling, et al.
Transfusion|August 29, 2006
Efficacy of single-dose pegfilgrastim after chemotherapy for the mobilization of autologous peripheral blood stem cells in patients with malignant lymphoma or multiple myelomaFrank Kroschinsky, Kristina Hölig, Uwe Platzbecker, et al.
Haematologica|December 7, 2005
Single-dose pegfilgrastim for the mobilization of allogeneic CD34+ peripheral blood progenitor cells in healthy family and unrelated donorsFrank Kroschinsky, Kristina Hölig, Kirsten Poppe-Thiede, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2009
Pharmacogenetic analyses of a phase III trial in metastatic gastroesophageal adenocarcinoma with fluorouracil and leucovorin plus either oxaliplatin or cisplatin: a study of the arbeitsgemeinschaft internistische onkologieEray Goekkurt, Salah-Eddin Al-Batran, Jörg T Hartmann, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 13, 2009
Graft-versus-host disease prophylaxis with everolimus and tacrolimus is associated with a high incidence of sinusoidal obstruction syndrome and microangiopathy: results of the EVTAC trialUwe Platzbecker, Malte von Bonin, Eray Goekkurt, et al.
Pageof 41